Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 218
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #233: FDA Floats Ibogaine Trial Design; Compass Talks Pricing; Potential LSD, Psilocybin Brand Names
Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic Public Health
Weekly Psychedelic Policy Briefing: October 5, 2026
Podcast: Oregon Backtracks on Fee Hike, California Funds Psychedelic Research, DEA Moves to Schedule 5 Tryptamines
Psychedelic Churches Need Psychedelic Seminaries
MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC
COMP360 psilocybin study of 89 healthy participants published in Journal of...
Psychedelic Bulletin: First Look at Field Trip’s FT-104 Molecule; MindMed Trial...
PT280 – Danny Peterson – Psychedelics, Religion, and Freedom
Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge...
MindMed Announces Transitions to Management Team
COMPASS Patent Challenge Targets Crystallography Errors
PT279 – Joe Zap & Kevin Whalen – Cannabis Acceptance, Conspiratorial...
PTSF90 – Colorado’s Natural Medicine Healing Act and Guidelines for Emergency...
Numinus Wellness Commends Health Canada on Special Access Programme Amendments to...
Load more